News US authorities probe marketing of J&J drugs US authorities suspicious over marketing, rebates and payment support programmes.
News Call for inquiry into NHS contaminated blood scandal Former health secretary says scandal was "criminal" cover-up.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
News Can Gilead find another Pharmasset in 2017? Company needs to make acquisition to grow, admits CEO.
Views & Analysis Novartis muscles into NASH fatty liver disease Company's Eric Hughes on what it takes to be leader in NASH - and what can be learnt from hepatitis C.
News New Gilead and AbbVie hepatitis C combos filed in EU Companies aim to cut treatment time and side effects.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
